116 related articles for article (PubMed ID: 32424700)
1. A population perspective on the use of external beam radiotherapy in Catalonia, Spain.
Corral J; Solà J; Galceran J; Marcos-Gragera R; Carulla M; Izquierdo Á; Vilardell L; Llauradó L; Espinàs JA; Borras JM
Clin Transl Oncol; 2020 Dec; 22(12):2222-2229. PubMed ID: 32424700
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
4. [Trends in cervix cancer mortality in Catalonia, 1975-1992: analysis of death certificates and cancer registry of Girona].
Sánchez Garrido MV; Izquierdo Font A; Beltrán Fabregat M; Bosch José FX; Viladiu Quemada P
Gac Sanit; 1996; 10(53):67-72. PubMed ID: 8755158
[TBL] [Abstract][Full Text] [Related]
5. [The risk of breast cancer in Catalonia].
Izquierdo A; Viladiu P; Borrás J; Galcerán J; Borràs JM; Dorca J; Vayreda J; Moreno V
Med Clin (Barc); 1996 Oct; 107(11):410-3. PubMed ID: 9045002
[TBL] [Abstract][Full Text] [Related]
6. Cancer incidence and mortality projections up to 2020 in Catalonia by means of Bayesian models.
Ribes J; Esteban L; Clèries R; Galceran J; Marcos-Gragera R; Gispert R; Ameijide A; Vilardell ML; Borras J; Puigdefabregas A; Buxó M; Freitas A; Izquierdo A; Borras JM
Clin Transl Oncol; 2014 Aug; 16(8):714-24. PubMed ID: 24338506
[TBL] [Abstract][Full Text] [Related]
7. [Cancer incidence in Catalonia, 1998-2002].
Marcos-Gragera R; Cardó X; Galceran J; Ribes J; Izquierdo A; Borràs J
Med Clin (Barc); 2008 Oct; 131 Suppl 1():4-10. PubMed ID: 19080809
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy access in Belgium: How far are we from evidence-based utilisation?
Lievens Y; De Schutter H; Stellamans K; Rosskamp M; Van Eycken L;
Eur J Cancer; 2017 Oct; 84():102-113. PubMed ID: 28802187
[TBL] [Abstract][Full Text] [Related]
9. Impact of non-adherence to radiotherapy on 1-year survival in cancer patients in Catalonia, Spain.
Borras JM; Font R; Solà J; Macia M; Tuset V; Arenas M; Eraso A; Verges R; Farré N; Pedro A; Mollà M; Algara M; Solé JM; Mira M; Espinàs JA
Radiother Oncol; 2020 Oct; 151():200-205. PubMed ID: 32771615
[TBL] [Abstract][Full Text] [Related]
10. The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis.
Borras JM; Lievens Y; Dunscombe P; Coffey M; Malicki J; Corral J; Gasparotto C; Defourny N; Barton M; Verhoeven R; van Eycken L; Primic-Zakelj M; Trojanowski M; Strojan P; Grau C
Radiother Oncol; 2015 Jul; 116(1):38-44. PubMed ID: 25981052
[TBL] [Abstract][Full Text] [Related]
11. Infrastructure of radiotherapy in Spain: a minimal standard of radiotherapy resources.
Esco R; Palacios A; Pardo J; Biete A; Carceller JA; Veiras C; Vazquez G;
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):319-27. PubMed ID: 12738304
[TBL] [Abstract][Full Text] [Related]
12. Cancer incidence in AIDS patients in Catalonia, Spain.
Galceran J; Marcos-Gragera R; Soler M; Romaguera A; Ameijide A; Izquierdo A; Borràs J; de Sanjosé S; Casabona J
Eur J Cancer; 2007 Apr; 43(6):1085-91. PubMed ID: 17349785
[TBL] [Abstract][Full Text] [Related]
13. Predicting the cancer burden in Catalonia between 2015 and 2025: the challenge of cancer management in the elderly.
Clèries R; Ameijide A; Marcos-Gragera R; Pareja L; Carulla M; Vilardell ML; Esteban L; Buxó M; Espinàs JA; Puigdefàbregas A; Ribes J; Izquierdo A; Galceran J; Borrás JM
Clin Transl Oncol; 2018 May; 20(5):647-657. PubMed ID: 29027110
[TBL] [Abstract][Full Text] [Related]
14. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
15. Consistency of variables in PCS and JASTRO great area database.
Nishino T; Teshima T; Abe M; Ikeda H; Oguchi M; Hirokawa Y; Hiraoka M; Inoue T; Yamashita T; Nishio M; Niibe H; Mori T; Masuda K; Harauchi H; Inamura K
Radiat Med; 1998; 16(6):449-55. PubMed ID: 9929145
[TBL] [Abstract][Full Text] [Related]
16. [Time trend of breast cancer incidence in Catalonia].
Izquierdo A; González JR; Moreno V; Galceran J; Marcos-Gragera R; Clèries R; Borràs J
Med Clin (Barc); 2006 Mar; 126(8):286-9. PubMed ID: 16527154
[TBL] [Abstract][Full Text] [Related]
17. Outcomes and prognostic factors in intermediate-risk prostate cancer: multi-institutional analysis of the Spanish RECAP database.
Hervás A; Pastor J; González C; Jové J; Gómez A; Casaña M; Villafranca E; Mengual JL; Muñoz V; Henriquez I; Muñoz J; Collado E; Clemente J
Clin Transl Oncol; 2019 Jul; 21(7):900-909. PubMed ID: 30536208
[TBL] [Abstract][Full Text] [Related]
18. The need for radiotherapy in Europe in 2020: Not only data but also a cancer plan.
Borras JM; Lievens Y; Grau C
Acta Oncol; 2015; 54(9):1268-74. PubMed ID: 26213310
[TBL] [Abstract][Full Text] [Related]
19. The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project.
Borras JM; Barton M; Grau C; Corral J; Verhoeven R; Lemmens V; van Eycken L; Henau K; Primic-Zakelj M; Strojan P; Trojanowski M; Dyzmann-Sroka A; Kubiak A; Gasparotto C; Defourny N; Malicki J; Dunscombe P; Coffey M; Lievens Y
Radiother Oncol; 2015 Jul; 116(1):45-50. PubMed ID: 26002304
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy.
Ito K; Shimizuguchi T; Karasawa K
Jpn J Clin Oncol; 2019 Mar; 49(3):270-275. PubMed ID: 30576504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
